Drug · CHEMBL582
ISOPROPYL ALCOHOL
7 sourcespipelines-2026-09-18-0.3.1
Cite this record
ConductScience Library. ISOPROPYL ALCOHOL. Drugs and targets, record CHEMBL582. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL582
On this page
Drug
Names and IDs as ChEMBL gives them, through Open Targets.
- Brand names
- Isopropyl alcohol component of chloraprep, Isopropyl alcohol component of duraprep, Isopropyl alcohol component of soluprep, Manugel, Medi-swab, Medi-swab h, Sterets, Sterets h, Swim-ear, Zuragard
- ChEMBL
- Other names
- 2-propanol, 2-propanolum, Alcohol,isopropyl, FEMA NO. 2929, Isopropanol, NSC-135801
- ChEMBL
Targets0
The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.
None in this release.
Diseases12
The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
| Disease | Open Targets' stage | Stage reported by | Reports | Of them trials | Its drugs |
|---|---|---|---|---|---|
| infection | Approval | DailyMed | 6 | 3 | https://conductscience.org/library/drugs?q=EFO_0000544 |
| Nausea | Phase 2/3 | ClinicalTrials.gov | 3 | 3 | https://conductscience.org/library/drugs?q=HP_0002018 |
| Vomiting | Phase 2/3 | ClinicalTrials.gov | 3 | 3 | https://conductscience.org/library/drugs?q=HP_0002013 |
| skin infection | Approval | DailyMed | 2 | 0 | https://conductscience.org/library/drugs?q=MONDO_0021201 |
| anemia (phenotype) | Approval | DailyMed | 1 | 0 | https://conductscience.org/library/drugs?q=EFO_0004272 |
| ankylosing spondylitis | Approval | DailyMed | 1 | 0 | https://conductscience.org/library/drugs?q=MONDO_0005306 |
| burn | Approval | DailyMed | 1 | 0 | https://conductscience.org/library/drugs?q=EFO_0009516 |
| prostate carcinoma | Approval | DailyMed | 1 | 0 | https://conductscience.org/library/drugs?q=MONDO_0005159 |
| psoriasis | Approval | DailyMed | 1 | 0 | https://conductscience.org/library/drugs?q=MONDO_0005083 |
| psoriatic arthritis | Approval | DailyMed | 1 | 0 | https://conductscience.org/library/drugs?q=MONDO_0011849 |
1 to 10 of 12Source Open Targets
See all 12 diseasesTrials24
Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs. 2 more rest on that reading alone and are shown because the trials' posted result groups or NLM's indexing of their papers name the drug. 5 more that Open Targets linked to it are not shown, since the release's checks do not confirm them.
| Trial | Title | Phase | Participants | Results first posted | Named as | Linked by | Source |
|---|---|---|---|---|---|---|---|
| NCT02831816 | Clinical Evaluation of Patient Preoperative Prep | Phase 3 | 640 | 2021-07-16 | ZuraGard | Its name | ClinicalTrials.gov |
| NCT02831998 | In-vivo Efficacy of Patient Preoperative Prep | Phase 3 | 440 | 2021-07-19 | ZuraGard | Its name | ClinicalTrials.gov |
| NCT01968707 | In-vivo Efficacy Study of Patient Pre-operative Preps | Phase 3 | 426 | 2021-06-09 | isopropyl alcohol | Its name | ClinicalTrials.gov |
| NCT04218110 | Preoperative Skin Preparation Study to Evaluate the Antimicrobial Capabilities of Four Test Substances | Phase 3 | 329 | 2021-10-22 | isopropyl alcohol | Its name | ClinicalTrials.gov |
| NCT04756154 | Efficacy Study of Patient Preoperative Preps In-vivo | Phase 3 | 154 | 2023-08-01 | chlorhexidine gluconate/isopropyl alcohol | A combination that names it | ClinicalTrials.gov |
| NCT01563406 | Hub Cleansing to Prevent Hub Infection | 149 | 2016-04-18 | isopropyl alcohol | Its name | ClinicalTrials.gov | |
| NCT02760069 | Isopropyl Alcohol vs Ondansetron for Nausea in the Emergency Department | Phase 4 | 122 | 2020-07-23 | isopropyl alcohol | Its name | ClinicalTrials.gov |
| NCT03155178 | In Vivo Preoperative Skin Preparation Persistence Evaluation | Phase 2 | 69 | 2020-02-28 | chloraprep | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov |
| NCT02618343 | EMS Use of Isopropyl Alcohol Aromatherapy Versus Ondansetron | 51 | 2021-03-24 | isopropyl alcohol | Its name | ClinicalTrials.gov | |
| NCT04756804 | Perioperative Patient Skin Antiseptic Preparation Evaluation | Phase 3 | 51 | 2024-03-20 | isopropyl alcohol | Its name | ClinicalTrials.gov |
1 to 10 of 24
See all 24 trialsComparisons in its trials7
Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.
| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Isopropyl Alcohol vs Ondansetron Group: deaths from any cause | 0 of 28 | 0 of 23 | 51 | NCT02618343 | Trial comparisons |
| Isopropyl Alcohol vs Ondansetron Group: Number of Subjects That Required Rescue Ondansetron | 0 of 23 | 2 of 28 | 51 | NCT02618343 | Trial comparisons |
| Isopropyl Alcohol vs Ondansetron Group: serious adverse events | 0 of 28 | 0 of 23 | 51 | NCT02618343 | Trial comparisons |
| 70% Isopropyl Alcohol Novel Preoperative Skin Antiseptic vs 2% Chlorhexidine Gluconate/70% Isopropyl Alcohol Preoperative Skin Antiseptic: Surgical Site Infection Occurrence | 0 of 25 | 1 of 26 | 51 | NCT04756804 | Trial comparisons |
| 70% Isopropyl Alcohol Novel Preoperative Skin Antiseptic vs 2% Chlorhexidine Gluconate/70% Isopropyl Alcohol Preoperative Skin Antiseptic: deaths from any cause | 0 of 25 | 1 of 26 | 51 | NCT04756804 | Trial comparisons |
| 70% Isopropyl Alcohol Novel Preoperative Skin Antiseptic vs 2% Chlorhexidine Gluconate/70% Isopropyl Alcohol Preoperative Skin Antiseptic: Allergic Reaction and Skin Irritation | 1 of 25 | 1 of 26 | 51 | NCT04756804 | Trial comparisons |
| 70% Isopropyl Alcohol Novel Preoperative Skin Antiseptic vs 2% Chlorhexidine Gluconate/70% Isopropyl Alcohol Preoperative Skin Antiseptic: serious adverse events | 10 of 25 | 11 of 26 | 51 | NCT04756804 | Trial comparisons |
Papers from its trials4
The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
Tests in its trials0
The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.
None in this release.
Data dates
The date of each source this release read.
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this drug from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL582
GET https://conductscience.org/api/drugs/v1/CHEMBL582/trials?page=2